A Case Report of Curative Surgery for Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination after Gemcitabine Chemotherapy

Yoshitoshi Ichikawa, Daisaku Yamada, Hidetoshi Eguchi, Yoshifumi Iwagami, Takehiro Noda, Tadafumi Asaoka, Hiroshi Wada, Koichi Kawamoto, Kunihito Gotoh, Shogo Kobayashi, Mitsuaki Tatsumi, Misa Takeyari, Masaki Mori, Yuichiro Doki

Research output: Contribution to journalArticle

Abstract

A 70-year-old man was diagnosed with pancreatic ductal adenocarcinoma(PDAC)with peritoneal dissemination and received systemic chemotherapy of gemcitabine(GEM)plus nab-paclitaxel. Since the patient could not continue the regimen due to an adverse event of liver dysfunction, he was administered GEM alone except for the first administration. GEM monotherapy resulted in remarkable anti-tumor effects with a distinct decrease of both tumor markers and size. Peritoneal metastases were not detected in images after 12 courses of the GEM regimen, and the vanished tumor metastasis in images was maintained until 16 courses were administered. After the laparoscopic examination proved no peritoneal metastasis, we performed curative surgery. The presence of peritoneal metastasis of PDAC indicated that it was at a lethal stage; however, a few cases were reported as receiving curative surgery after chemotherapy with modest long-term survival. We herein report a rare case of curative surgery following chemotherapy with GEM alone for unresectable PDAC accompanied with peritoneal dissemination.

Original languageEnglish
Pages (from-to)2014-2016
Number of pages3
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume44
Issue number12
Publication statusPublished - Nov 1 2017

Fingerprint

gemcitabine
Adenocarcinoma
Drug Therapy
Neoplasm Metastasis
Tumor Biomarkers
Liver Diseases
Neoplasms
Survival

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Ichikawa, Y., Yamada, D., Eguchi, H., Iwagami, Y., Noda, T., Asaoka, T., ... Doki, Y. (2017). A Case Report of Curative Surgery for Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination after Gemcitabine Chemotherapy. Gan to kagaku ryoho. Cancer & chemotherapy, 44(12), 2014-2016.

A Case Report of Curative Surgery for Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination after Gemcitabine Chemotherapy. / Ichikawa, Yoshitoshi; Yamada, Daisaku; Eguchi, Hidetoshi; Iwagami, Yoshifumi; Noda, Takehiro; Asaoka, Tadafumi; Wada, Hiroshi; Kawamoto, Koichi; Gotoh, Kunihito; Kobayashi, Shogo; Tatsumi, Mitsuaki; Takeyari, Misa; Mori, Masaki; Doki, Yuichiro.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 44, No. 12, 01.11.2017, p. 2014-2016.

Research output: Contribution to journalArticle

Ichikawa, Y, Yamada, D, Eguchi, H, Iwagami, Y, Noda, T, Asaoka, T, Wada, H, Kawamoto, K, Gotoh, K, Kobayashi, S, Tatsumi, M, Takeyari, M, Mori, M & Doki, Y 2017, 'A Case Report of Curative Surgery for Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination after Gemcitabine Chemotherapy', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 44, no. 12, pp. 2014-2016.
Ichikawa, Yoshitoshi ; Yamada, Daisaku ; Eguchi, Hidetoshi ; Iwagami, Yoshifumi ; Noda, Takehiro ; Asaoka, Tadafumi ; Wada, Hiroshi ; Kawamoto, Koichi ; Gotoh, Kunihito ; Kobayashi, Shogo ; Tatsumi, Mitsuaki ; Takeyari, Misa ; Mori, Masaki ; Doki, Yuichiro. / A Case Report of Curative Surgery for Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination after Gemcitabine Chemotherapy. In: Gan to kagaku ryoho. Cancer & chemotherapy. 2017 ; Vol. 44, No. 12. pp. 2014-2016.
@article{8e51d04182aa4d82888f8dca6dbe327c,
title = "A Case Report of Curative Surgery for Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination after Gemcitabine Chemotherapy",
abstract = "A 70-year-old man was diagnosed with pancreatic ductal adenocarcinoma(PDAC)with peritoneal dissemination and received systemic chemotherapy of gemcitabine(GEM)plus nab-paclitaxel. Since the patient could not continue the regimen due to an adverse event of liver dysfunction, he was administered GEM alone except for the first administration. GEM monotherapy resulted in remarkable anti-tumor effects with a distinct decrease of both tumor markers and size. Peritoneal metastases were not detected in images after 12 courses of the GEM regimen, and the vanished tumor metastasis in images was maintained until 16 courses were administered. After the laparoscopic examination proved no peritoneal metastasis, we performed curative surgery. The presence of peritoneal metastasis of PDAC indicated that it was at a lethal stage; however, a few cases were reported as receiving curative surgery after chemotherapy with modest long-term survival. We herein report a rare case of curative surgery following chemotherapy with GEM alone for unresectable PDAC accompanied with peritoneal dissemination.",
author = "Yoshitoshi Ichikawa and Daisaku Yamada and Hidetoshi Eguchi and Yoshifumi Iwagami and Takehiro Noda and Tadafumi Asaoka and Hiroshi Wada and Koichi Kawamoto and Kunihito Gotoh and Shogo Kobayashi and Mitsuaki Tatsumi and Misa Takeyari and Masaki Mori and Yuichiro Doki",
year = "2017",
month = "11",
day = "1",
language = "English",
volume = "44",
pages = "2014--2016",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "12",

}

TY - JOUR

T1 - A Case Report of Curative Surgery for Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination after Gemcitabine Chemotherapy

AU - Ichikawa, Yoshitoshi

AU - Yamada, Daisaku

AU - Eguchi, Hidetoshi

AU - Iwagami, Yoshifumi

AU - Noda, Takehiro

AU - Asaoka, Tadafumi

AU - Wada, Hiroshi

AU - Kawamoto, Koichi

AU - Gotoh, Kunihito

AU - Kobayashi, Shogo

AU - Tatsumi, Mitsuaki

AU - Takeyari, Misa

AU - Mori, Masaki

AU - Doki, Yuichiro

PY - 2017/11/1

Y1 - 2017/11/1

N2 - A 70-year-old man was diagnosed with pancreatic ductal adenocarcinoma(PDAC)with peritoneal dissemination and received systemic chemotherapy of gemcitabine(GEM)plus nab-paclitaxel. Since the patient could not continue the regimen due to an adverse event of liver dysfunction, he was administered GEM alone except for the first administration. GEM monotherapy resulted in remarkable anti-tumor effects with a distinct decrease of both tumor markers and size. Peritoneal metastases were not detected in images after 12 courses of the GEM regimen, and the vanished tumor metastasis in images was maintained until 16 courses were administered. After the laparoscopic examination proved no peritoneal metastasis, we performed curative surgery. The presence of peritoneal metastasis of PDAC indicated that it was at a lethal stage; however, a few cases were reported as receiving curative surgery after chemotherapy with modest long-term survival. We herein report a rare case of curative surgery following chemotherapy with GEM alone for unresectable PDAC accompanied with peritoneal dissemination.

AB - A 70-year-old man was diagnosed with pancreatic ductal adenocarcinoma(PDAC)with peritoneal dissemination and received systemic chemotherapy of gemcitabine(GEM)plus nab-paclitaxel. Since the patient could not continue the regimen due to an adverse event of liver dysfunction, he was administered GEM alone except for the first administration. GEM monotherapy resulted in remarkable anti-tumor effects with a distinct decrease of both tumor markers and size. Peritoneal metastases were not detected in images after 12 courses of the GEM regimen, and the vanished tumor metastasis in images was maintained until 16 courses were administered. After the laparoscopic examination proved no peritoneal metastasis, we performed curative surgery. The presence of peritoneal metastasis of PDAC indicated that it was at a lethal stage; however, a few cases were reported as receiving curative surgery after chemotherapy with modest long-term survival. We herein report a rare case of curative surgery following chemotherapy with GEM alone for unresectable PDAC accompanied with peritoneal dissemination.

UR - http://www.scopus.com/inward/record.url?scp=85046476931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046476931&partnerID=8YFLogxK

M3 - Article

C2 - 29394852

AN - SCOPUS:85046476931

VL - 44

SP - 2014

EP - 2016

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 12

ER -